IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 49 filers reported holding IBERE PHARMACEUTICALS in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,300,944 | +1.8% | 327,150 | 0.0% | 0.10% | +33.3% |
| Q3 2022 | $3,242,000 | +10.2% | 327,150 | +9.0% | 0.08% | +14.7% |
| Q2 2022 | $2,943,000 | 0.0% | 300,000 | 0.0% | 0.07% | +1.5% |
| Q1 2022 | $2,943,000 | +1.1% | 300,000 | 0.0% | 0.07% | -11.8% |
| Q4 2021 | $2,910,000 | +0.1% | 300,000 | 0.0% | 0.08% | -10.6% |
| Q3 2021 | $2,907,000 | +0.2% | 300,000 | 0.0% | 0.08% | -6.6% |
| Q2 2021 | $2,901,000 | – | 300,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |